I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 42 800 VND
Market Cap: 6.6T VND
Have any thoughts about
Imexpharm Corp?
Write Note

Imexpharm Corp
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Imexpharm Corp
Capital Expenditures Peer Comparison

Comparables:
H
DHT
C
DCL
D
DMC
D
DHG
T
TRA

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
I
Imexpharm Corp
VN:IMP
Capital Expenditures
-â‚«83.7B
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
-14%
H
HaTay Pharmaceutical JSC
VN:DHT
Capital Expenditures
-â‚«287.1B
CAGR 3-Years
-24%
CAGR 5-Years
-45%
CAGR 10-Years
-44%
C
Cuu Long Pharmaceutical JSC
VN:DCL
Capital Expenditures
-â‚«222.9B
CAGR 3-Years
-30%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Capital Expenditures
-â‚«9.1B
CAGR 3-Years
-8%
CAGR 5-Years
28%
CAGR 10-Years
14%
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Capital Expenditures
-â‚«319.1B
CAGR 3-Years
-70%
CAGR 5-Years
-49%
CAGR 10-Years
3%
T
Traphaco JSC
VN:TRA
Capital Expenditures
-â‚«101.3B
CAGR 3-Years
-25%
CAGR 5-Years
-21%
CAGR 10-Years
-10%

See Also

What is Imexpharm Corp's Capital Expenditures?
Capital Expenditures
-83.7B VND

Based on the financial report for Jun 30, 2024, Imexpharm Corp's Capital Expenditures amounts to -83.7B VND.

What is Imexpharm Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-14%

Over the last year, the Capital Expenditures growth was 4%. The average annual Capital Expenditures growth rates for Imexpharm Corp have been 3% over the past three years , 9% over the past five years , and -14% over the past ten years .

Back to Top